Gene · 3381
Papers4,417
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
361 to 380 of 4,417
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| PAX5-miR-142 feedback loop promotes breast cancer proliferation by regulating DNMT1 and ZEB1. | Mol Med | 2023 | 37403081 | PubTator, text mining | PubMed |
| Galectin-3 Plays an Important Role in BMP7-Induced Cementoblastic Differentiation of Human Periodontal Ligament Cells by Interacting with Extracellular Components. | Stem Cells Int | 2023 | 37396953 | PubTator, text mining | PubMed |
| The recent progress of peptide regulators for the Wnt/β-catenin signaling pathway. | Front Med (Lausanne) | 2023 | 37396899 | PubTator, text mining | PubMed |
| Osteoderms in a mammal the spiny mouse Acomys and the independent evolution of dermal armor. | iScience | 2023 | 37378333 | PubTator, text mining | PubMed |
| The Role of Extracellular Matrix (ECM) Adhesion Motifs in Functionalised Hydrogels. | Molecules | 2023 | 37375171 | PubTator, text mining | PubMed |
| Pre- and Post-Transcriptional Control of HBV Gene Expression: The Road Traveled towards the New Paradigm of HBx, Its Isoforms, and Their Diverse Functions. | Biomedicines | 2023 | 37371770 | PubTator, text mining | PubMed |
| Inverse Regulation of Cartilage Neogenesis at Physiologically Relevant Calcium Conditions by Human Articular Chondrocytes and Mesenchymal Stromal Cells. | Cells | 2023 | 37371129 | PubTator, text mining | PubMed |
| RUNX Family as a Promising Biomarker and a Therapeutic Target in Bone Cancers: A Review on Its Molecular Mechanism(s) behind Tumorigenesis. | Cancers (Basel) | 2023 | 37370857 | PubTator, text mining | PubMed |
| Integrating Multi-Omics Analysis for Enhanced Diagnosis and Treatment of Glioblastoma: A Comprehensive Data-Driven Approach. | Cancers (Basel) | 2023 | 37370767 | PubTator, text mining | PubMed |
Complete Remission in Paralytic Late Tick-Borne Neurological Disease Comprising Mixed Involvement of Borrelia, Babesia, Anaplasma, and Bartonella: Use of Long-Term Treatments with Antibiotics and Antiparasitics in a Series of 10 Cases. | Antibiotics (Basel) | 2023 | 37370340 | PubTator, text mining | PubMed |
| Osteogenic Potential of Nano-Hydroxyapatite and Strontium-Substituted Nano-Hydroxyapatite. | Nanomaterials (Basel) | 2023 | 37368310 | PubTator, text mining | PubMed |
| SP7 gene silencing dampens bone marrow stromal cell hypertrophy, but it also dampens chondrogenesis. | J Tissue Eng | 2023 | 37362901 | PubTator, text mining | PubMed |
| Osteoclast-derived IGF1 induces RANKL production in osteocytes and contributes to pagetic lesion formation. | JCI Insight | 2023 | 37338990 | PubTator, text mining | PubMed |
| In skeletal muscle and neural crest cells, SMCHD1 regulates biological pathways relevant for Bosma syndrome and facioscapulohumeral dystrophy phenotype. | Nucleic Acids Res | 2023 | 37334829 | PubTator, text mining | PubMed |
| Inhibition of Osteoclast Differentiation and Promotion of Osteogenic Formation by Wolfiporia extensa Mycelium. | J Microbiol Biotechnol | 2023 | 37317624 | PubTator, text mining | PubMed |
| Exploring the Role of Urocortin in Osteoporosis. | Cureus | 2023 | 37313093 | PubTator, text mining | PubMed |
| Chromatin reprogramming and bone regeneration in vitro and in vivo via the microtopography-induced constriction of cell nuclei. | Nat Biomed Eng | 2023 | 37308586 | PubTator, text mining | PubMed |
| Bone repair and key signalling pathways for cell-based bone regenerative therapy: A review. | J Taibah Univ Med Sci | 2023 | 37305024 | PubTator, text mining | PubMed |
| Tauroursodeoxycholic Acid Enhances Osteogenic Differentiation through EGFR/p-Akt/CREB1 Pathway in Mesenchymal Stem Cells. | Cells | 2023 | 37296585 | PubTator, text mining | PubMed |
| Spontaneous Osteogenic Differentiation of Human Mesenchymal Stem Cells by Tuna-Bone-Derived Hydroxyapatite Composites with Green Tea Polyphenol-Reduced Graphene Oxide. | Cells | 2023 | 37296569 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3381/papers?page=19